Amphastar Pharmaceuticals(DE:29A)
€25.51-0.14 (-0.55%)
DE:29A
Amphastar Pharmaceuticals earnings date
€25.51
At close:-0.14 (-0.55%)
Amphastar Pharmaceuticals (29A) Q3 2023 Earnings Report
2 Followers
DE:29A Q3 2023 EPS Results
- Actual EPS
- EUR 1.03
- Consensus EPS
- EUR 0.62
- Beat/Miss
- Beat by +EUR 0.41
- One Year Ago EPS
- EUR 0.34
DE:29A Q3 2023 Revenue Results
- Actual Revenue
- EUR 161.66M
- Expected Revenue
- EUR 156.35M
- Beat/Miss
- Beat by +EUR 5.31M
- YoY Revenue Growth
- +50.30%
Earnings Announcement Details
- Quarter
- Q3 2023
- Date
- 11/08/2023
- Time
- After Close
- Conference Call
- Wednesday, November 8, 2023
DE:29A Upcoming Earnings
Amphastar Pharmaceuticals's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q3 2023 Earnings Call Audio
DE:29A Q3 2023 Earnings Call
0:00 / 0:00
Q3 2023 Earnings Slide Deck
Q3 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:29A Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | 0.70- | 0.65 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | 0.771.02 | 0.83 | 22.58% (+0.19) | |
| Aug 06, 2026 | 2026 (Q2) | 0.560.81 | 0.76 | 7.06% (+0.05) | |
| May 07, 2026 | 2026 (Q1) | 0.630.38 | 0.66 | -43.24% (-0.29) | |
| Feb 26, 2026 | 2025 (Q4) | 0.810.65 | 0.82 | -20.65% (-0.17) | |
| Nov 06, 2025 | 2025 (Q3) | 0.740.83 | 0.86 | -3.13% (-0.03) | |
| Aug 07, 2025 | 2025 (Q2) | 0.660.76 | 0.84 | -9.57% (-0.08) | |
| May 07, 2025 | 2025 (Q1) | 0.620.66 | 0.93 | -28.85% (-0.27) | |
| Feb 27, 2025 | 2024 (Q4) | 0.840.82 | 0.79 | 4.55% (+0.04) | |
| Nov 06, 2024 | 2024 (Q3) | 0.880.86 | 1.03 | -16.52% (-0.17) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
